IDEX Biometrics ASA Logo

IDEX Biometrics ASA

0MTP.L

(0.0)
Stock Price

0,19 NOK

-176.23% ROA

-197.1% ROE

-0.21x PER

Market Cap.

86.269.430,00 NOK

351.14% DER

0% Yield

-758.75% NPM

IDEX Biometrics ASA Stock Analysis

IDEX Biometrics ASA Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

IDEX Biometrics ASA Fundamental Stock Analysis
# Analysis Rating
1 ROE

Unidentified ROE

2 ROA

Unidentified ROA

3 PBV

Unidentified ROA

4 DER

Unidentified DER

5 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

6 Net Profit Growth

Despite the passage of five years, this company's net profit has not shown any improvement, highlighting a lack of growth and making it a less appealing investment prospect.

7 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

8 Graham Number

Unidentified Graham Number

9 Dividend Growth

Investors should note the company's stagnant dividend growth over the past three years, indicating limited profitability and potentially diminishing returns.

10 Dividend

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

11 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock seems overpriced (0), indicating a potential drawback for investors as its market price exceeds its estimated intrinsic value.

IDEX Biometrics ASA Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

IDEX Biometrics ASA Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Sell
4 Stoch RSI Sell

IDEX Biometrics ASA Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

IDEX Biometrics ASA Revenue
Year Revenue Growth
2004 0
2005 0 0%
2006 18.634 100%
2007 0 0%
2008 3.729 100%
2009 518 -621.08%
2010 11.226 95.39%
2011 16.586 32.32%
2012 187.349 91.15%
2013 1.151 -16177.06%
2014 191.396 99.4%
2015 39.702 -382.08%
2016 4.460.156 99.11%
2017 1.952.863 -128.39%
2018 250.332 -680.11%
2019 158.285 -58.15%
2020 1.095.000 85.54%
2021 2.840.000 61.44%
2022 4.092.000 30.6%
2023 40.650.764 89.93%
2023 43.740.572 7.06%
2024 16.565.672 -164.04%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

IDEX Biometrics ASA Research and Development Expenses
Year Research and Development Expenses Growth
2004 301.430
2005 547.935 44.99%
2006 1.360.803 59.73%
2007 1.960.124 30.58%
2008 610.340 -221.15%
2009 860.922 29.11%
2010 1.067.886 19.38%
2011 2.258.577 52.72%
2012 1.924.895 -17.34%
2013 2.851.213 32.49%
2014 6.899.687 58.68%
2015 11.668.016 40.87%
2016 9.411.258 -23.98%
2017 6.850.854 -37.37%
2018 5.262.614 -30.18%
2019 4.375.413 -20.28%
2020 1.895.000 -130.89%
2021 2.680.000 29.29%
2022 3.250.000 17.54%
2023 36.114.996 91%
2023 36.943.765 2.24%
2024 27.236.544 -35.64%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

IDEX Biometrics ASA General and Administrative Expenses
Year General and Administrative Expenses Growth
2004 1.162.802
2005 1.379.995 15.74%
2006 2.527.710 45.41%
2007 2.939.360 14%
2008 1.494.014 -96.74%
2009 2.071.803 27.89%
2010 2.337.001 11.35%
2011 2.964.750 21.17%
2012 3.184.218 6.89%
2013 6.253.103 49.08%
2014 6.938.289 9.88%
2015 10.824.714 35.9%
2016 10.360.643 -4.48%
2017 17.655.540 41.32%
2018 18.477.457 4.45%
2019 0 0%
2020 20.578.000 100%
2021 21.107.000 2.51%
2022 19.213.000 -9.86%
2023 0 0%
2023 0 0%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

IDEX Biometrics ASA EBITDA
Year EBITDA Growth
2004 -2.167.078
2005 -3.311.189 34.55%
2006 -5.504.578 39.85%
2007 -5.874.678 6.3%
2008 -2.708.385 -116.91%
2009 -4.332.565 37.49%
2010 -4.681.658 7.46%
2011 -6.217.330 24.7%
2012 -5.919.945 -5.02%
2013 -10.449.683 43.35%
2014 -16.193.645 35.47%
2015 -24.656.786 34.32%
2016 -22.577.373 -9.21%
2017 -29.136.592 22.51%
2018 -27.194.114 -7.14%
2019 -30.346.924 10.39%
2020 -24.657.000 -23.08%
2021 -29.537.000 16.52%
2022 -29.921.000 1.28%
2023 -272.959.196 89.04%
2023 -278.151.140 1.87%
2024 -209.760.120 -32.6%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

IDEX Biometrics ASA Gross Profit
Year Gross Profit Growth
2004 0
2005 0 0%
2006 115.999 100%
2007 0 0%
2008 3.729 100%
2009 518 -621.08%
2010 11.226 95.39%
2011 16.586 32.32%
2012 187.349 91.15%
2013 2.526.000 92.58%
2014 135.982 -1757.6%
2015 86.343 -57.49%
2016 679.736 87.3%
2017 285.574 -138.02%
2018 77.935 -266.43%
2019 96.264 19.04%
2020 820.000 88.26%
2021 1.586.000 48.3%
2022 848.000 -87.03%
2023 9.285.492 90.87%
2023 -166.061.962 105.59%
2024 -118.670.448 -39.94%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

IDEX Biometrics ASA Net Profit
Year Net Profit Growth
2004 -2.219.536
2005 -3.342.033 33.59%
2006 -5.523.213 39.49%
2007 -6.187.431 10.73%
2008 -3.031.768 -104.09%
2009 -4.760.179 36.31%
2010 -4.750.549 -0.2%
2011 -6.258.377 24.09%
2012 -5.976.006 -4.73%
2013 -10.688.764 44.09%
2014 -16.558.146 35.45%
2015 -26.031.803 36.39%
2016 -23.512.182 -10.72%
2017 -31.113.081 24.43%
2018 -30.230.000 -2.92%
2019 -32.420.000 6.76%
2020 -26.750.000 -21.2%
2021 -32.550.000 17.82%
2022 -32.660.000 0.34%
2023 -300.815.668 89.14%
2023 -281.480.839 -6.87%
2024 -286.951.864 1.91%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

IDEX Biometrics ASA Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2004 0
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 -1 100%
2024 -1 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

IDEX Biometrics ASA Free Cashflow
Year Free Cashflow Growth
2004 -1.792.139
2005 -3.029.436 40.84%
2006 -4.572.209 33.74%
2007 -5.662.073 19.25%
2008 -3.113.940 -81.83%
2009 -4.154.997 25.06%
2010 -3.940.703 -5.44%
2011 -5.643.513 30.17%
2012 -5.430.795 -3.92%
2013 -6.015.174 9.72%
2014 -18.053.809 66.68%
2015 -21.406.892 15.66%
2016 -26.962.337 20.6%
2017 -29.510.335 8.63%
2018 -25.637.941 -15.1%
2019 -28.455.096 9.9%
2020 -23.627.000 -20.43%
2021 -27.606.000 14.41%
2022 -32.164.000 14.17%
2023 -285.349.628 88.73%
2023 -77.921.099 -266.2%
2024 -54.159.572 -43.87%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

IDEX Biometrics ASA Operating Cashflow
Year Operating Cashflow Growth
2004 -1.792.139
2005 -3.029.436 40.84%
2006 -4.572.209 33.74%
2007 -5.662.073 19.25%
2008 -3.113.940 -81.83%
2009 -4.154.997 25.06%
2010 -3.940.703 -5.44%
2011 -5.643.513 30.17%
2012 -5.430.795 -3.92%
2013 -6.015.174 9.72%
2014 -14.142.892 57.47%
2015 -21.314.405 33.65%
2016 -26.805.012 20.48%
2017 -28.639.486 6.41%
2018 -24.605.964 -16.39%
2019 -27.607.089 10.87%
2020 -23.294.000 -18.52%
2021 -27.465.000 15.19%
2022 -31.897.000 13.89%
2023 -282.781.006 88.72%
2023 -77.161.572 -266.48%
2024 -54.317.390 -42.06%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

IDEX Biometrics ASA Capital Expenditure
Year Capital Expenditure Growth
2004 0
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 3.910.917 100%
2015 92.487 -4128.66%
2016 157.325 41.21%
2017 870.849 81.93%
2018 1.031.977 15.61%
2019 848.006 -21.69%
2020 333.000 -154.66%
2021 141.000 -136.17%
2022 267.000 47.19%
2023 2.568.622 89.61%
2023 759.527 -238.19%
2024 -157.818 581.27%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

IDEX Biometrics ASA Equity
Year Equity Growth
2004 3.444.663
2005 510.120 -575.27%
2006 1.867.630 72.69%
2007 -136.163 1471.61%
2008 -1.402.090 90.29%
2009 -1.413.472 0.81%
2010 1.633.468 186.53%
2011 3.244.538 49.65%
2012 3.280.937 1.11%
2013 8.202.419 60%
2014 32.731.212 74.94%
2015 85.284.013 61.62%
2016 65.054.705 -31.1%
2017 41.047.405 -58.49%
2018 14.145.241 -190.19%
2019 17.733.978 20.24%
2020 12.514.000 -41.71%
2021 37.725.000 66.83%
2022 22.841.000 -65.16%
2023 140.833.509 83.78%
2023 115.104.703 -22.35%
2024 26.565.512 -333.29%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

IDEX Biometrics ASA Assets
Year Assets Growth
2004 3.890.314
2005 1.021.428 -280.87%
2006 3.038.232 66.38%
2007 3.150.128 3.55%
2008 1.015.751 -210.13%
2009 1.611.403 36.96%
2010 2.640.289 38.97%
2011 4.397.701 39.96%
2012 4.484.019 1.93%
2013 12.503.905 64.14%
2014 40.258.217 68.94%
2015 94.223.269 57.27%
2016 70.580.158 -33.5%
2017 44.991.615 -56.87%
2018 17.941.325 -150.77%
2019 23.365.923 23.22%
2020 17.006.000 -37.4%
2021 42.131.000 59.64%
2022 29.016.000 -45.2%
2023 213.694.658 86.42%
2023 253.506.583 15.7%
2024 155.432.205 -63.1%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

IDEX Biometrics ASA Liabilities
Year Liabilities Growth
2004 445.650
2005 511.307 12.84%
2006 1.170.602 56.32%
2007 3.286.291 64.38%
2008 2.417.842 -35.92%
2009 3.024.875 20.07%
2010 1.006.821 -200.44%
2011 1.153.163 12.69%
2012 1.203.082 4.15%
2013 4.301.485 72.03%
2014 7.527.004 42.85%
2015 8.939.256 15.8%
2016 5.525.453 -61.78%
2017 3.944.210 -40.09%
2018 3.796.083 -3.9%
2019 5.631.945 32.6%
2020 4.492.000 -25.38%
2021 4.406.000 -1.95%
2022 6.175.000 28.65%
2023 72.861.149 91.52%
2023 138.401.879 47.36%
2024 128.866.692 -7.4%

IDEX Biometrics ASA Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.08
Net Income per Share
-0.88
Price to Earning Ratio
-0.21x
Price To Sales Ratio
3.72x
POCF Ratio
-0.23
PFCF Ratio
-0.36
Price to Book Ratio
2.07
EV to Sales
7.24
EV Over EBITDA
-0.73
EV to Operating CashFlow
-0.7
EV to FreeCashFlow
-0.69
Earnings Yield
-4.66
FreeCashFlow Yield
-2.81
Market Cap
0,09 Bil.
Enterprise Value
0,17 Bil.
Graham Number
1.34
Graham NetNet
-0.2

Income Statement Metrics

Net Income per Share
-0.88
Income Quality
0.94
ROE
-2.93
Return On Assets
-1.43
Return On Capital Employed
-3.45
Net Income per EBT
1
EBT Per Ebit
0.98
Ebit per Revenue
-7.77
Effective Tax Rate
-0

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0.84
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.01
Operating Profit Margin
-7.77
Pretax Profit Margin
-7.59
Net Profit Margin
-7.59

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.83
Free CashFlow per Share
-0.83
Capex to Operating CashFlow
-0
Capex to Revenue
0.03
Capex to Depreciation
0.04
Return on Invested Capital
-2.07
Return on Tangible Assets
-1.76
Days Sales Outstanding
344.67
Days Payables Outstanding
21.34
Days of Inventory on Hand
147.91
Receivables Turnover
1.06
Payables Turnover
17.11
Inventory Turnover
2.47
Capex per Share
0

Balance Sheet

Cash per Share
0,08
Book Value per Share
0,09
Tangible Book Value per Share
0.06
Shareholders Equity per Share
0.09
Interest Debt per Share
0.36
Debt to Equity
3.51
Debt to Assets
0.6
Net Debt to EBITDA
-0.36
Current Ratio
1.05
Tangible Asset Value
0,02 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
27789975
Working Capital
0,01 Bil.
Intangibles to Total Assets
0.07
Average Receivables
0,02 Bil.
Average Payables
0,01 Bil.
Average Inventory
68449615
Debt to Market Cap
1.08

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

IDEX Biometrics ASA Dividends
Year Dividends Growth
2022 0

IDEX Biometrics ASA Profile

About IDEX Biometrics ASA

IDEX Biometrics ASA engages in the design, development, and sale of fingerprint authentication solutions in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific regions. The company's fingerprint authentication solutions are used primarily in contactless financial payment, access control, and smart cards, as well as card-based devices for the storage of digital currencies. It primarily serves manufacturers of smart cards for financial payment applications and biometric payment card markets. IDEX Biometrics ASA was incorporated in 1996 and is headquartered in Oslo, Norway.

CEO
Ms. Catharina Eklof
Employee
43
Address
Dronning Eufemias gate 16
Oslo, 0191

IDEX Biometrics ASA Executives & BODs

IDEX Biometrics ASA Executives & BODs
# Name Age
1 Ms. Marianne Bøe
Head of Investor Relations
70
2 Ms. Catharina Eklof
Chief Executive Officer
70
3 Mr. Paul Taylor
Vice President of Operations & Program Management
70
4 Ms. Sarah Mathews
Vice President of Human Resources
70
5 Svein Mathiassen
Co-Founder
70
6 Mr. John T. Kurtzweil
Chief Financial Officer
70
7 Mr. Anthony Eaton
Chief Technology Officer
70

IDEX Biometrics ASA Competitors

Almedio Inc. Logo
Almedio Inc.

7859.T

()
JTEC Corporation Logo
JTEC Corporation

2479.T

()